whitepaper

Article: Linking genomics with proteomics to accelerate the search for drug targets

Posted: 30 March 2021 | | No comments yet

Several recent studies highlight the promise of combining genomics and proteomics to uncover new, robust drug targets.

Research summary article of three recently published research studies that highlight the importance of linking genetic and protein expression data in the context of disease phenotypes in order to identify actionable protein targets for drug development.












    To read this article in full, please complete the form below:

     









    This specialist content is provided to you free-of-charge thanks to the kind support of Olink

    By clicking submit you confirm that you accept our terms and conditions and privacy policy.

    Related organisations

    Send this to a friend